Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates
Corbett, K. S.; Nason, M.; Flach, B.; Gagne, M.; O'Connell, S.; Johnston, T.; Shah, S. N.; Edara, V. V.; Floyd, K.; Lai, L.; McDanal, C.; Francica, J.; Flynn, B.; Wu, K.; Choi, A.; Koch, M.; Abiona, O. M.; Werner, A. P.; Alvarado, G. S.; Andrew, S. F.; Donaldson, M. M.; Fintzi, J.; Flebbe, D.; Lamb, E.; Noe, A.; Nurmukhambetova, S.; Provost, S.; Cook, A.; Dodson, A.; Faudree, A.; Greenhouse, J.; Kar, S.; Pessaint, L.; Porto, M.; Steingrebe, K.; Valentin, D.; Zouantcha, S.; Bock, K.; Mahnaz, M.; Nagata, B.; Moliva, J. I.; van de Wetering, R.; Boyoglu-Barnum, S.; Leung, K.; Shi, W.; Yang, E. S.;
Show abstract
Immune correlates of protection can be used as surrogate endpoints for vaccine efficacy. The nonhuman primate (NHP) model of SARS-CoV-2 infection replicates key features of human infection and may be used to define immune correlates of protection following vaccination. Here, NHP received either no vaccine or doses ranging from 0.3 - 100 g of mRNA-1273, a mRNA vaccine encoding the prefusion-stabilized SARS-CoV-2 spike (S-2P) protein encapsulated in a lipid nanoparticle. mRNA-1273 vaccination elicited robust circulating and mucosal antibody responses in a dose-dependent manner. Viral replication was significantly reduced in bronchoalveolar lavages and nasal swabs following SARS-CoV-2 challenge in vaccinated animals and was most strongly correlated with levels of anti-S antibody binding and neutralizing activity. Consistent with antibodies being a correlate of protection, passive transfer of vaccine-induced IgG to naive hamsters was sufficient to mediate protection. Taken together, these data show that mRNA-1273 vaccine-induced humoral immune responses are a mechanistic correlate of protection against SARS-CoV-2 infection in NHP. One-Sentence SummarymRNA-1273 vaccine-induced antibody responses are a mechanistic correlate of protection against SARS-CoV-2 infection in NHP.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine 97%
- SARS-CoV-2 binding and neutralizing antibody levels after vaccination with Ad26.COV2.S predict durable protection in rhesus macaques 96%
- Immunologic and Biophysical Features of the BNT162b2 JN.1- and KP.2-Adapted COVID-19 Vaccines 96%
Similar papers in this journal
- Mapping SARS-CoV-2 antigenic relationships and serological responses 96%
- Low dose mRNA-1273 COVID-19 vaccine generates durable T cell memory and antibodies enhanced by pre-existing crossreactive T cell memory 96%
- Rapid isolation of potent SARS-CoV-2 neutralizing antibodies and protection in a small animal model 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.